Back to Search Start Over

Early acute rejection after lung transplantation mimicking viral pneumonia in the middle of COVID-19 pandemic: A case report.

Authors :
Palleschi, Alessandro
Rosso, Lorenzo
Morlacchi, Letizia Corinna
Del Gobbo, Alessandro
Ramondetta, Miriam
Gori, Andrea
Blasi, Francesco
Nosotti, Mario
Source :
International Journal of Surgery Case Reports; 2020, Vol. 77, p80-85, 6p
Publication Year :
2020

Abstract

• An atypical clinical presentation of early antibody-mediated rejection in COVID era. • The radiological features mimicked SARS-CoV2 pneumonia, but tests were negative. • This is the first report of lung transplantation in the COVID era in Europe. • Decide whether to keep lung transplantation programmes open in a COVID Hospital. In addition to morbidity and mortality rate per se , COVID-19 outbreak leads to potential 'side effects', which are difficult to evaluate and predict. Lung transplantation is a consolidated treatment for end-stage chronic lung disease requiring significantly demanding management. Deciding whether to keep transplant programmes open during an epidemic of this size is not easy, as immunosuppressed subjects face the risk of infection and related mortality. Additionally, there is a chance for the patient's standard care process to be compromised. We report the case of a patient undergoing bilateral lung transplantation during the explosion of COVID-19 epidemic in Lombardy; he died from definite early acute antibody-mediated rejection, clinically (persistent high fever, unresponsive to treatment) and radiologically mimicking viral pneumonia but persistently negative for SARS-CoV-2. The diagnosis was difficult given this atypical presentation, confounded by global scenario. Grafts were procured from a donation after circulatory death donor in an uncontrolled setting and a donor-recipient transmission was possible. Our institute became a COVID-Hospital right during the first post-transplantation days. Radiological imaging had the same features of SARS-CoV-2 pneumonia. This is the first report of lung transplantation of the COVID-19 era in Europe. Our extremely fragile patient was COVID-19 free up to the end. Donor-recipient transmission is conceivable, but the risk should be assessed with respect to waiting list mortality. Ultimately, treating COVID-19 patients can be a resource-consuming activity but we decided to keep our centre open. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
22102612
Volume :
77
Database :
Supplemental Index
Journal :
International Journal of Surgery Case Reports
Publication Type :
Academic Journal
Accession number :
147791946
Full Text :
https://doi.org/10.1016/j.ijscr.2020.10.105